ClinicalTrials.Veeva

Menu

A User Study With Vernivia® for Bacterial Vaginosis. (USV01)

P

Pharmiva

Status

Completed

Conditions

Bacterial Vaginoses

Treatments

Device: D005 vaginal mousse

Study type

Interventional

Funder types

Industry
Other

Identifiers

Details and patient eligibility

About

This is an open user study to evaluate D005 vagnial mousse with regards to user-friendliness, and measure time from start of treatment to symptom relief and measure the clarity of instructional material.

The study will be conducted at seven sites in Sweden, the study population will consist of up to 100 female subjects.

Enrollment

76 patients

Sex

Female

Ages

16 to 49 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age 16 - 49 years Informed consent to take part in the study Bacterial vaginosis (based on self-assessment or diagnosed by a doctor or midwife) Access to a smartphone

Exclusion criteria

  • Symptoms of vaginal candida infection and/or Pregnancy

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

76 participants in 1 patient group

One dose daily for 7 consequtive days (dose acc to IFU)
Other group
Description:
Open user study with Vernivia once daily for 7 consequtive days. Dosage according to IFU/Instructions For Use.
Treatment:
Device: D005 vaginal mousse

Trial contacts and locations

7

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems